Company Filing History:
Years Active: 2018-2020
Title: Diane Sau Mun Cohen: Innovating Healthcare with Anti-CD40 Antibodies
Introduction:
Diane Sau Mun Cohen, hailing from San Jose, CA, is a brilliant inventor and patent holder who has made significant contributions to the field of healthcare. With a robust portfolio of patents, Diane has worked diligently to develop novel anti-CD40 antibodies that hold great promise for treating various diseases. Currently associated with AbbVie Biotherapeutics Inc., Diane strives to make a positive impact on the healthcare industry through her innovative research and pioneering inventions.
Latest Patents:
Diane's recent patents revolve around the development of anti-CD40 antibodies. The first patent, titled "Anti-CD40 antibody," encompasses a novel antibody that targets CD40, a protein involved in immune responses. With this invention, Diane has opened doors for the creation of new therapies and treatments that can modulate immune responses effectively. Her second patent, also titled "Anti-CD40 antibodies," focuses on similar compositions and methods, highlighting her commitment to this field of research.
Career Highlights:
Throughout her career, Diane Sau Mun Cohen has showcased exceptional skills in the field of healthcare innovation. Her expertise in developing anti-CD40 antibodies has garnered attention from industry professionals and researchers alike. By designing new antibodies, she has shown the potential to revolutionize the treatment of diseases that involve immune system dysregulation. Diane's commitment to advancing medical science through her patents is truly commendable.
Collaborations:
Diane Cohen has had the opportunity to collaborate with esteemed colleagues during her journey of innovation. Notably, she has worked closely with Diane Hollenbaugh and Shiming Ye, who have also contributed significantly to this field. By joining forces and sharing their expertise, these inventors have brought forth groundbreaking inventions that have the potential to shape the future of healthcare.
Conclusion:
Diane Sau Mun Cohen's contributions to the healthcare industry through her patents on anti-CD40 antibodies highlight her dedication to advancing medical science. Her work at AbbVie Biotherapeutics Inc. and collaborations with other notable inventors demonstrate her commitment to pushing the boundaries of innovation. As Diane continues to delve into the realm of healthcare research, her inventions promise to pave the way for groundbreaking treatments and therapies. With her passion and expertise, Diane Sau Mun Cohen is undoubtedly a prominent figure in the realm of healthcare innovation.